NCT00581464

Brief Summary

80 nicotine dependent adults ages 18-65 who desire to quit smoking will be screened and, if eligible, enrolled and randomized to one of two four-week treatments for smoking cessation. The treatments are standard behavioral therapy and Mindfulness Based Addiction Therapy (MBAT), which is standard therapy plus mindfulness. Standard therapy and MBAT incorporate elements of widely-used tools for smoking cessation including managing craving and strong emotions, problem solving, tips on healthy eating and keeping active, and exercises based on cognitive and behavioral therapy. MBAT uniquely incorporates mindfulness practice (a relaxation therapy) into standard therapy. Participants complete questionnaires and undergo an fMRI scan at baseline and at the end of therapy (after they complete the 4 weeks of standard therapy or MBAT). During each scan, participants will complete a validated smoking-related cue paradigm and a validated affect labeling paradigm.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
79

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2009

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 20, 2007

Completed
7 days until next milestone

First Posted

Study publicly available on registry

December 27, 2007

Completed
1.8 years until next milestone

Study Start

First participant enrolled

November 1, 2009

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2010

Completed
Last Updated

April 27, 2017

Status Verified

April 1, 2017

Enrollment Period

1.1 years

First QC Date

December 20, 2007

Last Update Submit

April 25, 2017

Conditions

Keywords

Smoking cessationTobacco dependenceMindfulnessfMRICraving

Outcome Measures

Primary Outcomes (1)

  • Smoking Cessation

    week 2 and 6 month follow-up

Secondary Outcomes (8)

  • Exhaled CO readings

    baseline, weeks 2-4, post class follow-up, long term follow-up

  • Saliva Test

    baseline

  • Functional Magnetic Resonance Imaging

    baseline & follow-up

  • Urine Pregnancy Test

    baseline & follow-up

  • Nicotine Replacement Therapy

    Week 1

  • +3 more secondary outcomes

Study Arms (2)

1

ACTIVE COMPARATOR
Behavioral: Standard Behavioral Therapy

2

ACTIVE COMPARATOR
Behavioral: Mindfulness Based Addiction Therapy

Interventions

Standard therapy to help participants with smoking cessation.

1

A novel mind body therapy that extends basic behavioral therapy principles to include the practice of mindfulness, which fosters a dispassionate approach to the experience of craving.

2

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Participants will be considered eligible for enrollment if they are between 18-65 years old, smoke at least ½ pack cigarettes per day, desire to quit smoking (self-reported 75+ out of a possible 100), and have no contraindications for varenicline medication therapy or fMRI scanning (such as body weight over 250 lbs, intravascular metal devices including stents, or claustrophobia).

You may not qualify if:

  • Participants will not be considered eligible for enrollment if they are not between 18-65 years old, smoke less than ½ pack cigarettes per day, do not desire to quit smoking (self-reported -75 out of a possible 100), or have contraindications for varenicline medication therapy or fMRI scanning (such as body weight over 250 lbs, intravascular metal devices including stents, or claustrophobia).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Pittsburgh

Pittsburgh, Pennsylvania, 15213, United States

Location

MeSH Terms

Conditions

SmokingSmoking CessationTobacco Use Disorder

Condition Hierarchy (Ancestors)

BehaviorHealth BehaviorSubstance-Related DisordersChemically-Induced DisordersMental Disorders

Study Officials

  • Hilary Tindle, MD

    University of Pittsburgh

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 20, 2007

First Posted

December 27, 2007

Study Start

November 1, 2009

Primary Completion

December 1, 2010

Study Completion

December 1, 2010

Last Updated

April 27, 2017

Record last verified: 2017-04

Locations